IL91901A - Production of liposomes with improved stability during drying - Google Patents

Production of liposomes with improved stability during drying

Info

Publication number
IL91901A
IL91901A IL91901A IL9190189A IL91901A IL 91901 A IL91901 A IL 91901A IL 91901 A IL91901 A IL 91901A IL 9190189 A IL9190189 A IL 9190189A IL 91901 A IL91901 A IL 91901A
Authority
IL
Israel
Prior art keywords
liposomes
production
stability during
improved stability
during drying
Prior art date
Application number
IL91901A
Other languages
English (en)
Other versions
IL91901A0 (en
Original Assignee
Vestar Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vestar Inc filed Critical Vestar Inc
Publication of IL91901A0 publication Critical patent/IL91901A0/xx
Publication of IL91901A publication Critical patent/IL91901A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/829—Liposomes, e.g. encapsulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Cosmetics (AREA)
IL91901A 1988-10-05 1989-10-05 Production of liposomes with improved stability during drying IL91901A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US25368088A 1988-10-05 1988-10-05

Publications (2)

Publication Number Publication Date
IL91901A0 IL91901A0 (en) 1990-06-10
IL91901A true IL91901A (en) 1993-06-10

Family

ID=22961272

Family Applications (1)

Application Number Title Priority Date Filing Date
IL91901A IL91901A (en) 1988-10-05 1989-10-05 Production of liposomes with improved stability during drying

Country Status (13)

Country Link
US (1) US5817334A (ja)
EP (1) EP0437479B1 (ja)
JP (1) JP2792702B2 (ja)
AT (1) ATE107502T1 (ja)
AU (1) AU612285B2 (ja)
CA (1) CA2000219A1 (ja)
DE (1) DE68916439T2 (ja)
DK (1) DK59691D0 (ja)
FI (1) FI902249A0 (ja)
IE (1) IE64559B1 (ja)
IL (1) IL91901A (ja)
NO (1) NO180363C (ja)
WO (1) WO1990003795A1 (ja)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5705187A (en) * 1989-12-22 1998-01-06 Imarx Pharmaceutical Corp. Compositions of lipids and stabilizing materials
WO1993004672A1 (en) * 1991-09-11 1993-03-18 Pitman-Moore, Inc. Method for enhancing the immune system in a host employing liposome-encapsulated polypeptides
JP3329554B2 (ja) * 1993-03-10 2002-09-30 千葉製粉株式会社 乾燥小胞体
DE4341472A1 (de) * 1993-12-02 1995-06-08 Schering Ag Verfahren zur Erhöhung der Stabilität von hydrophile Wirkstoffe enthaltenden Liposomensuspensionen
US5589189A (en) * 1994-09-14 1996-12-31 Nexstar Pharmaceuticals, Inc. Liposome dispersion
CA2202103C (en) * 1996-04-11 2007-01-09 Toshiaki Tagawa Method for preparing closed vesicles
GB9813100D0 (en) * 1998-06-18 1998-08-19 Secr Defence Method of forming liposomes
WO2000053177A1 (fr) * 1999-03-11 2000-09-14 Fujisawa Pharmaceutical Co., Ltd. Preparations liposomiques
CA2309373A1 (en) * 1999-05-27 2000-11-27 Johnson & Johnson Consumer Companies, Inc. Novel topical formulations
DK1059092T3 (da) * 1999-06-08 2006-03-27 Gentium Spa Anvendelse af komplekser af kationiske liposomer og polydeoxyribonukleotider som medikamenter
EP1192466B1 (en) * 1999-06-23 2004-08-11 Cornell Research Foundation, Inc. Dehydration/rehydration of marked liposomes on a test device
US6576460B1 (en) 1999-10-28 2003-06-10 Cornell Research Foundation, Inc. Filtration-detection device and method of use
JPWO2002038128A1 (ja) * 2000-11-10 2004-03-11 科学技術振興事業団 小胞体分散液の製造方法
US7125568B2 (en) * 2001-08-23 2006-10-24 Sung Michael T Lipophilic drug compositions
WO2003041681A2 (en) * 2001-11-13 2003-05-22 Celator Technologies, Inc. Lipid carrier compositions with enhanced blood stability
DE60333876D1 (de) 2002-05-31 2010-09-30 Cornell Res Foundation Inc Methoden zum Nachweis Analyten in Proben
DE10233632A1 (de) * 2002-07-24 2004-02-05 Wilex Ag Formulierungen von Phenylalanin-Derivaten
WO2004017944A1 (en) * 2002-08-23 2004-03-04 Neopharm, Inc. Liposomal gemcitabine compositions for better drug delivery
WO2004043363A2 (en) * 2002-11-06 2004-05-27 Azaya Therapeutics, Inc. Protein-stabilized liposomal formulations of pharmaceutical agents
US7521187B2 (en) * 2002-12-23 2009-04-21 Vical Incorporated Method for freeze-drying nucleic acid/block copolymer/cationic surfactant complexes
US7381422B2 (en) * 2002-12-23 2008-06-03 Vical Incorporated Method for producing sterile polynucleotide based medicaments
US20060223050A1 (en) * 2003-08-06 2006-10-05 The Regents Of The University Of California Office Of Technology Transfer Therapeutic platelets and methods
DE602005018043D1 (de) * 2004-05-17 2010-01-14 Tekmira Pharmaceuticals Corp Liposomale formulierungen mit dihydrosphingomyelin und verfahren zu ihrer verwendung
FR2870741B1 (fr) * 2004-05-25 2008-03-14 Coletica Sa Phase lamellaires hydratees ou liposomes, contenant une monoamine grasse ou un polymere cationique favorisant la penetration intercellulaire, et composition cosmetique ou pharmaceutique la contenant.
AU2005302255A1 (en) * 2004-10-28 2006-05-11 Alza Corporation Lyophilized liposome formulations and method
WO2006068759A2 (en) * 2004-11-22 2006-06-29 Magellan Companies, Inc. Liposomes containing phytochemical agents and methods for making and using same
EP1932517A3 (en) * 2006-12-11 2008-07-16 Universiteit Utrecht Holding B.V. Liposomes containing a polyphenol derivative such as caffeic acid and a method of post-loading thereof
US20090047336A1 (en) * 2007-08-17 2009-02-19 Hong Kong Baptist University novel formulation of dehydrated lipid vesicles for controlled release of active pharmaceutical ingredient via inhalation
US8962015B2 (en) * 2007-09-28 2015-02-24 Sdg, Inc. Orally bioavailable lipid-based constructs
CN101485629B (zh) * 2008-01-16 2013-01-23 沈阳药科大学 一种给药系统及其制备方法
US8771743B2 (en) * 2008-07-24 2014-07-08 Amorepacific Corporation Multi-layered lamellar granule and skin external application composition containing same
ES2593862T3 (es) * 2009-03-09 2016-12-13 Molecular Express, Inc. Métodos y composiciones de formulación liposomal de antígenos y usos de los mismos
US9775819B2 (en) 2009-09-16 2017-10-03 R.P. Scherer Technologies, Llc Oral solid dosage form containing nanoparticles and process of formulating the same using fish gelatin
EP2386647A1 (de) * 2010-05-10 2011-11-16 Qiagen GmbH Verfahren zur Transfektion einer eurkaryotischen Zelle
EP2471511A1 (en) 2011-01-04 2012-07-04 Archivel Farma, SL Liposome formulation suitable for treating or preventing tuberculosis
CN108853031A (zh) * 2011-10-21 2018-11-23 切拉托尔制药公司 冻干脂质体
US10076496B2 (en) * 2011-11-11 2018-09-18 The Chinese University Of Hong Kong Engineering of polymer-stabilized nanoparticles for drugs with Log P values below 6 by controlled antisolvent precipitation
EA022183B1 (ru) * 2012-12-24 2015-11-30 Общество С Ограниченной Ответственностью "Технология Лекарств" Способ получения липосомальной формы цитохрома с
US11471401B2 (en) 2014-08-28 2022-10-18 The General Hospital Corporation Injectable slurries and methods of manufacturing the same
US11504322B2 (en) 2014-08-28 2022-11-22 The General Hospital Corporation Injectable slurries and methods of manufacturing the same
CN117064838A (zh) 2014-08-28 2023-11-17 通用医疗公司 可注射的浆料及其制造和使用方法
SG10201913504XA (en) 2016-02-26 2020-03-30 Massachusetts Gen Hospital Medical ice slurry production and delivery systems and methods
EP4003295A1 (en) * 2019-07-24 2022-06-01 The General Hospital Corporation Methods of creating a substance with different freezing points by encapsulation
CN114886785B (zh) * 2022-06-07 2023-02-03 美尚(广州)化妆品股份有限公司 一种三元冻干组合物及其在冻干制剂中的应用

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5186117A (en) * 1975-01-27 1976-07-28 Tanabe Seiyaku Co Johoseibiryushiseizainoseiho
CH621479A5 (ja) * 1977-08-05 1981-02-13 Battelle Memorial Institute
US4460577A (en) * 1977-09-30 1984-07-17 Farmitalia Carlo Erba S.P.A. Pharmaceutical compositions consisting or consisting essentially of liposomes, and processes for making same
FR2416008A1 (fr) * 1978-02-02 1979-08-31 Oreal Lyophilisats de liposomes
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4193983A (en) * 1978-05-16 1980-03-18 Syva Company Labeled liposome particle compositions and immunoassays therewith
US4377567A (en) * 1978-10-02 1983-03-22 The Procter & Gamble Company Lipid membrane drug delivery
CA1173360A (en) * 1979-06-22 1984-08-28 Jurg Schrank Pharmaceutical preparations
JPS574913A (en) * 1980-06-11 1982-01-11 Green Cross Corp:The Urokinase preparation for oral administration
JPS5746921A (en) * 1980-09-02 1982-03-17 Green Cross Corp:The Oral preparation of human blood coagulation factor
US4460560A (en) * 1982-06-18 1984-07-17 University Of Southern California Drug delivery by polymeric carriers
AU1629383A (en) * 1982-10-02 1984-04-05 Amano Seiyaku K.K. Earthworm tissue protease thrombolytic agents
US4544545A (en) * 1983-06-20 1985-10-01 Trustees University Of Massachusetts Liposomes containing modified cholesterol for organ targeting
US4914084A (en) * 1984-05-09 1990-04-03 Synthetic Blood Corporation Composition and method for introducing heme, hemoproteins, and/or heme-hemoprotein complexes into the body
US5008109A (en) * 1984-05-25 1991-04-16 Vestar, Inc. Vesicle stabilization
US4880635B1 (en) * 1984-08-08 1996-07-02 Liposome Company Dehydrated liposomes
AU587600B2 (en) * 1985-01-11 1989-08-24 Regents Of The University Of California, The Method for preserving liposomes
US4857319A (en) * 1985-01-11 1989-08-15 The Regents Of The University Of California Method for preserving liposomes
CA1256372A (en) * 1985-04-11 1989-06-27 Koichiro Miyazima Process for producing liposome composition
US4735210A (en) * 1985-07-05 1988-04-05 Immunomedics, Inc. Lymphographic and organ imaging method and kit
US4766046A (en) * 1985-09-27 1988-08-23 Liposome Technology, Inc. Stabilized liposome/amphotericin composition and method
IE58981B1 (en) * 1985-10-15 1993-12-15 Vestar Inc Anthracycline antineoplastic agents encapsulated in phospholipid micellular particles
GB8604983D0 (en) * 1986-02-28 1986-04-09 Biocompatibles Ltd Protein preservation
US5089181A (en) * 1987-02-24 1992-02-18 Vestar, Inc. Method of dehydrating vesicle preparations for long term storage
EP0395765A4 (en) * 1988-01-13 1991-09-25 Dainippon Pharmaceutical Co., Ltd. Oozing-proof liposome preparation
JPH02273538A (ja) * 1989-04-13 1990-11-08 Fuji Photo Film Co Ltd リポソームの保存方法
US5705187A (en) * 1989-12-22 1998-01-06 Imarx Pharmaceutical Corp. Compositions of lipids and stabilizing materials

Also Published As

Publication number Publication date
IE64559B1 (en) 1995-08-23
DE68916439D1 (de) 1994-07-28
CA2000219A1 (en) 1990-04-05
AU4340089A (en) 1990-05-01
WO1990003795A1 (en) 1990-04-19
IL91901A0 (en) 1990-06-10
DE68916439T2 (de) 1994-10-20
NO180363B (no) 1996-12-30
EP0437479A4 (en) 1991-10-16
NO901852D0 (no) 1990-04-26
JPH04500803A (ja) 1992-02-13
US5817334A (en) 1998-10-06
DK59691A (da) 1991-04-04
AU612285B2 (en) 1991-07-04
NO901852L (no) 1990-08-01
EP0437479B1 (en) 1994-06-22
NO180363C (no) 1997-04-09
FI902249A0 (fi) 1990-05-04
IE893196L (en) 1990-04-05
DK59691D0 (da) 1991-04-04
ATE107502T1 (de) 1994-07-15
JP2792702B2 (ja) 1998-09-03
EP0437479A1 (en) 1991-07-24

Similar Documents

Publication Publication Date Title
IL91901A0 (en) Production of liposomes with improved stability during drying
EP0283713A3 (en) Complexes of saponins with phospholipids and pharmaceutical and cosmetic compositions containing them
JPS6447389A (en) Production of active protein
CA2113995A1 (en) Use of gentisic acid or gentisyl alcohol for stabilising radiolabeled peptides and proteins
EP0141374A3 (en) Capsule production using biologically active substrates
DE3479632D1 (en) Fibronolytically active hybrid protein, process for its preparation and pharmaceutical composition
IE881755L (en) Novel proteins with factor viii activity, process for their¹preparation using genetically engineered cells and¹pharmaceutical compositions containing them
PL304600A1 (en) Human insulin preparation and method of obtaining same
HUT44415A (en) Fungicides comprising alpha-aryl-alpha-phenyl-ethyl-1h 1,2,4 triazole-1-propanenitrile derivatives as active substance and process for preparing the active substance
DE3266590D1 (en) Lipid and protein containing material in particulate form and process therefor
HUT39971A (en) Pesticide compositions containing 3,5-diaryl-1,2,4-triazole derivatives as active ingredients and process for preparing the active substances
ES8305501A1 (es) Procedimiento para preparar un material de referencia o control de hemoglobina.
HUT44414A (en) Pesticide comprising 1,2,3,6 tetrahydro-5-nitropyrimidine derivatives as active substance and process for preparing the active substance
HUT41365A (en) Insecticide compositions containing substituted benzyl-ether derivatives as active ingredients and process for preparing the active substances
HUT34766A (en) Process for producing new, natural lb-rh antagonistic peptides and erivatives, ndpharmaceutical compositions containing them as active ingredients
HUT41398A (en) Insecticidal compositions comprising tetrazolyl derivatives as active substance and process for preparing the active substances
PT81429A (en) Process for preparing solid drug formulations and stable suspensions containing 4-hydroxy- or 4-aciloxi-4-androstene-3,17-diones
EP0315118A3 (en) Dna coding for endothelin and use thereof
HUT35155A (en) Pesticide composition containing heterocyclic nitro-methylene derivatives as active substances and process for preparing the active substance
HUT42761A (en) Fungicidal composition comprising phenyl-sulfonyl-azole derivatives as active substance and process for preparing the active substance
HUT37710A (en) Insecticide and fungicide composition containing azolyl-propanol derivatives as active substances and process for preparing the active substances
Krasnikov et al. Crystal structure of the double triphosphate FeNH sub (4) HP sub (3) O sub (10).
HUT37892A (en) Process for stabilizing physiologically active material prepared by recombinat dna technique, and for preparing aqueous solution or powder containing this material
HUT33951A (en) Pesticide composition and process for producing tetrahydo-thio-pirane-3,5-dione-4-carboxamide derivatives utilizable as active agents
HUT34456A (en) Pesticide compositions containing new quinqzoline derivatives and process for preparing the active substances

Legal Events

Date Code Title Description
HE Change of address of proprietor(s)
RH Patent void
EXP Patent expired